AN INVESTIGATION OF THE RELATIONSHIP BETWEEN THE eNOS GENE POLYMORPHISM AND DIAGNOSED MIGRAINE
Güler S1,*, Gürkan H2, Tozkir H2, Turan N3, Çelik Y1
*Corresponding Author: Sibel Güler, M.D., Department of Neurology, Trakya University Faculty of Medicine, Balkan Yerleşkesi, 22030 Edirne, Turkey. Tel: +90-284-236-49-81. Fax: +90-284-223-42-03. E-mail: drsibleguler@ yahoo.com
page: 49

REFERENCES

1. Borroni B, Rao R, Liberini P, Venturelli E, Cossandi M, Archetti S, et al. Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache. 2006; 46(10): 1575-1579. 2. Toriello M, Oterino A, Pascual J, Castillo J, Colás R, Alonso-Arranz A, et al. Lack of association of endothelial nitricoxide synthase polymorphisms and migraine. Headache. 2008; 48(7): 1115-1119. 3. Gruber HJ, Bernecker C, Lechner A, Weiss S, Wallner-Blazek m, Meinitzer A, et al. Increased nitric oxide stress is associated with migraine. Cephalalgia. 2010; 30(4): 486-492. 4. Gkaliagkousi E, Douma S, Zamboulis C, Ferro A. Nitric oxide dysfunction in vascular endothelium and platelets: Role in essential hypertension. J Hypertens. 2009; 27(12): 2310-2320. 5. Gonçalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, et al. Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol. 2011; 30(6): 363-369. 6. Headache Classification Committee, International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia. 2004; 24(1): 1-160. 7. Stovner, L, Hagen, K, Jensen, R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3): 193-210. 8. Gonçalves FM, Luizon MR, Speciali JG, Martins- Oliveira A, Dach F, Tanus-Santos JE, et al. Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem. 2012; 370(1-2): 183-189. 9. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008; 120(2): 157-171. 10. Olesen J. Nitric oxide-related drug targets in headache. Neurotherapeutics. 2010 7(2): 183-190. 11. Sarchielli P, Floridi A, Mancini ML, Rossi C, Coppola F, Baldi A, et al. NF-κB Activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia. 2006; 26(9): 1071- 1079. 12. de O S Mansur T, Gonçalves FM, Martins- Oliveira A, Speciali JG, Dach F, Lacchini R, et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem. 2012; 364(1-2): 303-308. 13. Lea RA, Curtain RP, Shepherd AG, Brimage PJ, Griffiths LR. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet. 2001; 105(1): 110-113. 14. Jia S, Ni J, Chen S, Jiang Y, Dong W, Gao Y. Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population. DNA Cell Biol. 2011; 30(2): 117-122. 15. Noseda R, Kainz V, Jakubowski M, Gooley JJ, Saper CB, Digre K, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010; 13(2): 239-245. 16. Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology. 2001; 57(10): 1805-1811. 17. Olesen J. Nitric oxide-related drug targets in headache. Neurotherapeutics. 2010; 7(2): 183-190. 18. Napoli R, Guardasole V, Zarra E, Matarazzo M, D’Anna C, Saccà F, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology. 2009; 72(24): 2111-2114. 19. Myers DE. Potential neurogenic and vascular roles of nitric oxide in migraine headache and aura. Headache. 1999; 39(2): 118-124. 20. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001; 1(8): 719-725. 21. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med. 2005; 56(1): 303-320. 22. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, et al. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics. 2005; 15(8): 565-570. 23. Wang J, Dudley D, Wang XL. Haplotype-specific effects on endothelial NO synthase promoter efficiency: Modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol. 2002; 22(5): e1-e4. 24. Lauer T, Kleinbongard P, Kelm M. Indexes of NO bioavailability in human blood. News Physiol Sci. 2002; 17(6): 251-255. 25. Metzger IF, Sertorio JTC, Tanus-Santos JE. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol. 2006; 188(2): 123-127. 26. Metzger IF, Sertório JT, Tanus-Santos JE. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med. 2007; 43(6): 987-992. 27. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE. Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Phar-macogenomics J. 2011; 11(6): 393-399. 28. Metzger IF, Luizon MR, Lacchini R, Ishizawa MH, Tanus-Santos JE. Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in Black subjects. Nitric Oxide. 2013; 28(1): 33-38. 29. Sipahi T, Guldiken B, Kabayel L, Palabıyık O, Oskan H, Kılıç TO, et al. Endothelial nitric oxide synthase and angiotensin converting enzyme gene polymorphisms in migraine patients. Arch Neuropsychiatr. 2013; 50(1): 274-278. 30. Guldiken B, Sipahi T, Guldiken S, Ustundag S, Budak M, Turgut N, et al. Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke. Mol Biol Rep. 2009; 36(6): 1539-1543. 31. Martelletti P, Lulli P, Morellini M, Mariani B, Pennesi G, Cappellacci S, et al. Chromosome 6pencoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. Hum Immunol. 1999; 60(1): 69-74. 32. Rainero I, Grimaldi LM, Salani G, Valfrè W, Rivoiro C, Savi L, et al. Association between the tumor necrosis factor-α –308 G/A gene polymorphism and migraine. Neurology. 2004; 62(1): 141-143. 33. Rubino E, Fenoglio P, Gallone S, Govone F, Vacca A, De Martino P, et al. Genetic variants in the NOTCH4 gene influence the clinical features of migraine. J Headache Pain. 2013; 14(1): 28-32.



Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006